Chalmers, James;
Crichton, Megan;
Goeminne, Pieter;
Cao, Bin;
Humbert, Marc;
Shteinberg, Michal;
Antoniou, Katerina;
Suppli Ulrik, Charlotte;
Parks, Helen;
Wang, Chen;
Vandendriessche, Thomas;
Qu, Jieming;
Stolz, Daiana;
Brightling, Christopher;
Welte, Tobias;
Aliberti, Stefano;
Simonds, Anita;
Tonia, Thomy;
Roche, Nicolas.
Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of SARS-CoV-2 infection have a high mortality rate and frequently require noninvasive respiratory support or invasive ventilation. Optimising and standardising management through evidence-based guidelines may improve quality of ca...
La enfermedad por el Coronavirus 2019 (COVID-19) es una patología respiratoria de humanos producida por SARS-CoV-2. El 11 de marzo de 2020 la Organización Mundial de la Salud (OMS) declaró al COVID-19 como una pandemia, y desde ese momento se han reportado en Argentina más de 3.000.000 casos confirma...
Ofrecer recomendaciones basadas en la evidencia para la prevención, detección, tratamiento y seguimiento de las queratosis actínicas, con el fin de apoyar al personal de salud en los diferentes niveles de atención, buscando garantizar una atención integral, homogénea, con calidad, equidad y eficien...
Leukemia, Lymphoid/diagnosis,
Leukemia, Lymphoid/therapy,
Leukemia, Myeloid/diagnosis,
Leukemia, Myeloid/therapy,
Cytogenetic Analysis/methods,
Vincristine/therapeutic use,
Doxorubicin/therapeutic use,
Dexamethasone/therapeutic use,
Imatinib Mesylate/therapeutic use,
Dasatinib/therapeutic use,
Antibodies, Monoclonal/therapeutic use,
Drug Therapy, Combination,
Transplantation, Homologous
Zinzani, Pier Luigi;
Marchetti, Monia;
Billio, Atto;
Barosi, Giovanni;
Carella, Angelo Michele;
Lazzarino, Mario;
Martelli, Maurizio;
Rambaldi, Alessandro;
Rigacci, Luigi;
Tarella, Corrado;
Vitolo, Umberto;
Tura, Sante.
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...
Antibodies, Monoclonal,
Antibodies,
Antibodies, Monoclonal, Murine-Derived/therapeutic use,
Antineoplastic Agents,
Drug Administration Schedule,
Hematopoietic Stem Cell Transplantation,
Lymphoma, Follicular/pathology,
Lymphoma/therapy,
Neoplasm Staging,
Rituximab,
Time Factors
